Chris Prior

35+ years in pharmaceutical development; 25 INDs; 4 product approvals; founded and sold two biopharma companies (Principia, BioRexis) with exits exceeding $500 million; Raised $75 million as CEO of PhaseBIO; took Innovate Biopharmaceuticals 4 public; director of R&D at Aventis (now Sanofi), senior product development scientist at Biogen (7th

employee).